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reporting data on mortality and CVE after TAVI stratiﬁed by the occur-
rence of NOAF. The most updated or inclusive data for a given study
were selected. All studies were observational and the highest-quality
estimate availablewaspicked for the overallmeta-analysis, with the fol-
lowing ranking: adjusted with propensity score N adjusted with multi-
variable analysis N unadjusted. The number of events, participants,
hazard ratios (HR) and conﬁdence intervals (CI) for all-cause death
and CVE at 30-day and 1-year were abstracted. The results of all studies
were combined using a random-effects model to minimize heterogene-
ity among groups. Statistical heterogeneity was quantiﬁed with the I2
test. Systematic bias was explored with funnel plots. A 2-tailed alphaDear Editor,
Newly-onset atrial ﬁbrillation (NOAF) has emerged in the last few
years as a potential prognostic factor in patients undergoing transcath-
eter aortic valve implantation (TAVI). NOAF after TAVI could be detri-
mental due to atrio-ventricular dissynchrony resulting in reduced
cardiac output and increased ﬁlling pressures. In addition, NOAF could
be responsible for fatal cerebrovascular events (CVE). In the last few
years some studies explored the incidence and the prognostic impact
of NOAF after TAVI [1–5], and recently new large series have added to
our knowledge [6–8]. However, the incidence of NOAF varies signiﬁ-
cantly across registries (around 6–32%), with controversial ﬁndings on
its prognostic signiﬁcance, hence the rationale for a meta-analysis.
We searched MEDLINE, Scopus and Cochrane databases until
September 20, 2015 using Internet-based engines, with no language
restrictions using various keywords including “new-onset atrial ﬁbrilla-
tion” or “NOAF” and “transcatheter aortic valve implantation” or “TAVI”
or “TAVR”. The reference lists of relevant studies and reviews, editorialso-toracic-vascular Department,
124 Catania, Italy.
o).
.and letters were searched. The analysis was restricted to studies
of 5%was used for hypothesis testing. Statistical analysis was performed
with Review Manager (Version 5.2 Copenhagen).
A total of 8 studies encompassing 4959 patientswere included [1–8].
Overall, the mean incidence of NOAF was 10.1% (499 patients with
NOAF and 4460 patients in sinus rhythm after TAVI). Patients with
NOAF showed a borderline increase of 30-day and a signiﬁcant increase
in 1-year all-cause death compared with those in sinus rhythm (Fig. 1).
Conversely, CVE were signiﬁcantly increased at 30-day but non-
signiﬁcantly albeit numerically increased at 1-year follow-up in NOAF
patients (Fig. 2). The main limitation of this meta-analysis is related to
the differences in NOAF deﬁnition across the included studies. We
excluded the study by Tchetche et al. [9] because most recent data
from the FRANCE-2 registry were available [8].
In conclusion, this updated meta-analysis on the role of NOAF
on outcomes after TAVI supports the understanding that NOAF is
associated with clinical events after TAVI. Whether this is a causal or
spurious association demands further research in this ﬁeld.
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Fig. 1. Early and 1-year mortality after TAVI according to the occurrence of NOAF. Early and 1-year random-effects hazard ratios and 95% conﬁdence interval for all-cause
mortality after TAVI.
Fig. 2. Early and 1-year cerebrovascular events after TAVI according to the occurrence of NOAF. Early and 1-year random-effects hazard ratios and 95% conﬁdence interval for
cerebrovascular events after TAVI.
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